Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
917,771
-
Shares change
-
+292
-
Total reported value, excl. options
-
$50,227,000
-
Value change
-
+$15,880
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$54.72
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q3 2018
12 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q3 2018.
NOVOZYMES A S DKK 2.0 - COM has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 917,771 shares
.
Largest 10 shareholders include SOMERVILLE KURT F (214,510 shares), Hemenway Trust Co LLC (193,628 shares), Kidder Stephen W (109,348 shares), Broderick Brian C (108,202 shares), PUZO MICHAEL J (101,470 shares), Page Arthur B (42,500 shares), Delaney Dennis R (35,778 shares), Notis-McConarty Edward (31,156 shares), Dempze Nancy E (28,695 shares), and Fayerweather Charles (24,339 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.